CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Cash flows from operating activities:
Net earnings	$ 418,241	$ 347,230
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	85,150	93,319
Loss/(gain) on sale/disposal of long-lived assets	(84)	356
Deferred income taxes	8,915	5,538
Share-based compensation	24,123	16,610
Non-cash restructuring charges	0	468
Change in operating assets and liabilities, net of businesses acquired:
Receivables, net	(122,200)	(128,774)
Inventories, net	(103,885)	(86,139)
Accounts payable and accrued expenses	22,336	28,480
Deferred revenue	83,662	40,119
Pension and postretirement liabilities, net	(21,342)	(14,433)
Other current and long-term assets and liabilities	(38,974)	(12,116)
Net cash provided by operating activities	355,942	290,658
Cash flows from investing activities:
Proceeds from sale/disposal of long-lived assets	892	424
Additions to property, plant, and equipment	(81,310)	(52,054)
Grant proceeds for property, plant, and equipment	25,508	0
Proceeds from sale of equity securities	0	7,919
Additional consideration paid on prior year acquisitions	0	(9,619)
Net cash used for investing activities	(54,910)	(53,330)
Cash flows from financing activities:
Borrowings under revolving credit facility	133,600	271,354
Payments of revolving credit facilities	(133,600)	(260,854)
Principal payments on debt	0	(90,000)
Repurchases of common stock	(381,672)	(325,112)
Proceeds from share-based compensation	13,056	12,538
Dividends paid	(18,471)	(16,967)
Other	0	(940)
Net cash used for financing activities	(387,087)	(409,981)
Effect of exchange-rate changes on cash	(4,177)	13,038
Net decrease in cash and cash equivalents	(90,232)	(159,615)
Cash and cash equivalents at beginning of period	371,345	385,042
Cash and cash equivalents at end of period	$ 281,113	$ 225,427